421
Views
0
CrossRef citations to date
0
Altmetric
Musculoskeletal Pain/Rehabilitation

Different Types of Pain in Complex Regional Pain Syndrome Require a Personalized Treatment Strategy

ORCID Icon, ORCID Icon & ORCID Icon
Pages 4379-4391 | Received 29 Jul 2023, Accepted 13 Nov 2023, Published online: 26 Dec 2023

References

  • Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342(8878):1012–1016. doi:10.1016/0140-6736(93)92877-V
  • Harden RN, Bruehl S, Perez RSGM, et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for complex regional pain syndrome. Pain. 2010;150(2):268–274. doi:10.1016/j.pain.2010.04.030
  • Gierthmühlen J, Binder A, Baron R. Mechanism-based treatment in complex regional pain syndromes. Nat Rev Neurol. 2014;10(9):518–528. doi:10.1038/nrneurol.2014.140
  • Birklein F, Schlereth T. Complex regional pain syndrome—significant progress in understanding. Pain. 2015;156:S94–S103. doi:10.1097/01.j.pain.0000460344.54470.20
  • Bruehl S. Complex regional pain syndrome. BMJ. 2015;351:h2730. doi:10.1136/bmj.h2730
  • Mangnus TJP, Bharwani KD, Dirckx M, Huygen FJPM. From a symptom-based to a mechanism-based pharmacotherapeutic treatment in complex regional pain syndrome. Drugs. 2022;82:511–531. doi:10.1007/s40265-022-01685-4
  • Harden RN, McCabe CS, Goebel A, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 5th edition. Pain Med. 2022;23(Supplement_1):S1–S53. doi:10.1093/pm/pnac046
  • Ferraro MC, Cashin AG, Wand BM, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome‐ an overview of systematic reviews. Cochrane Database Syst Rev. 2023;6. doi:10.1002/14651858.CD009416.pub3
  • Goebel A, Birklein F, Brunner F, et al. The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria. Pain. 2021;162(9):2346–2348. doi:10.1097/j.pain.0000000000002245
  • Bruehl S, Maihofner C, Stanton-Hicks M, et al. Complex regional pain syndrome: evidence for warm and cold subtypes in a large prospective clinical sample. Pain. 2016;157(8):1674–1681. doi:10.1097/j.pain.0000000000000569
  • Dimova V, Herrnberger MS, Escolano-Lozano F, et al. Clinical phenotypes and classification algorithm for complex regional pain syndrome. Neurology. 2020;94(4):e357–e367. doi:10.1212/WNL.0000000000008736
  • Bruehl S, Harden RN, Galer BS, Saltz S, Backonja M, Stanton-Hicks M. Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain. 2002;95(1–2):119–124. doi:10.1016/S0304-3959(01)00387-6
  • Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082–2097. doi:10.1016/S0140-6736(21)00393-7
  • Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Hauser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397(10289):2098–2110. doi:10.1016/S0140-6736(21)00392-5
  • Loeser JD. IASP terminology. International Association For The Study Of Pain; 2022. Available from: https://www.iasp-pain.org/resources/terminology/. Accessed December 2, 2023.
  • Woolf CJ. What is this thing called pain? J Clin Invest. 2010;120(11):3742–3744. doi:10.1172/JCI45178
  • Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267–284. doi:10.1016/j.cell.2009.09.028
  • Pinho-Ribeiro FA, Verri WA Jr, Chiu IM. Nociceptor sensory neuron–immune interactions in pain and inflammation. Trends Immunol. 2017;38(1):5–19. doi:10.1016/j.it.2016.10.001
  • Loeser JD, Treede R-D. The Kyoto protocol of IASP basic pain terminology. Pain®. 2008;137(3):473–477. doi:10.1016/j.pain.2008.04.025
  • Mense S, Masi AT. Increased muscle tone as a cause of muscle pain. In: Mense S, Gerwin RD, editors. Muscle Pain: Understanding the Mechanisms. Springer Berlin Heidelberg; 2010:207–249.
  • Birklein F, Ajit SK, Goebel A, Perez R, Sommer C. Complex regional pain syndrome - phenotypic characteristics and potential biomarkers. Nat Rev Neurol. 2018;14(5):272–284. doi:10.1038/nrneurol.2018.20
  • Lenz M, Uceyler N, Frettloh J, et al. Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain. 2013;154(10):2142–2149. doi:10.1016/j.pain.2013.06.039
  • Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11(1):47–51. doi:10.1080/09629350210307
  • Birklein F, Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett. 2008;437(3):199–202. doi:10.1016/j.neulet.2008.03.081
  • Littlejohn G. Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Nat Rev Rheumatol. 2015;11(11):639–648. doi:10.1038/nrrheum.2015.100
  • David Clark J, Tawfik VL, Tajerian M, Kingery WS. Autoinflammatory and autoimmune contributions to complex regional pain syndrome. Mol Pain. 2018;14:1744806918799127. doi:10.1177/1744806918799127
  • Alexander GM, Peterlin BL, Perreault MJ, Grothusen JR, Schwartzman RJ. Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome. J Pain. 2012;13(1):10–20. doi:10.1016/j.jpain.2011.10.003
  • Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain. 2005;116(3):213–219. doi:10.1016/j.pain.2005.04.013
  • Bharwani KD, Dirckx M, Stronks DL, Dik WA, Schreurs MWJ, Huygen F. Elevated plasma levels of sIL-2R in complex regional pain syndrome: a pathogenic role for T-lymphocytes? Mediators Inflamm. 2017;2017:2764261. doi:10.1155/2017/2764261
  • Heyn J, Azad SC, Luchting B. Altered regulation of the T-cell system in patients with CRPS. Inflamm Res. 2019;68(1):1–6. doi:10.1007/s00011-018-1182-3
  • Dirckx M, Schreurs MW, de Mos M, Stronks DL, Huygen FJ. The prevalence of autoantibodies in complex regional pain syndrome type I. Mediators Inflamm. 2015;2015:718201. doi:10.1155/2015/718201
  • van Hilten JJ. Movement disorders in complex regional pain syndrome. Pain Med. 2010;11(8):1274–1277. doi:10.1111/j.1526-4637.2010.00916.x
  • Birklein F, Dimova V. Complex regional pain syndrome–up-to-date. Pain Rep. 2017;2(6). doi:10.1097/PR9.0000000000000624
  • Dirckx M, Stronks DL, van Bodegraven-Hof EA, Wesseldijk F, Groeneweg JG, Huygen FJ. Inflammation in cold complex regional pain syndrome. Acta Anaesthesiol Scand. 2015;59(6):733–739. doi:10.1111/aas.12465
  • Bharwani KD, Dik WA, Dirckx M, Huygen F. Highlighting the role of biomarkers of inflammation in the diagnosis and management of complex regional pain syndrome. Mol Diagn Ther. 2019;23(5):615–626. doi:10.1007/s40291-019-00417-x
  • Russo MA, Georgius P, Pires AS, et al. Novel immune biomarkers in complex regional pain syndrome. J Neuroimmunol. 2020;347:577330. doi:10.1016/j.jneuroim.2020.577330
  • Perez R, Geertzen JHB, Dijkstra PU, Dirckx M, Van Eijs F, Frölke JP. Updated Guidelines Complex Regional Pain Syndrome Type 1. Utrecht, Netherlands: The Dutch Pain Society; 2014.
  • Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management: stepping up the quality of its evaluation. JAMA. 1995;274(23):1870–1873. doi:10.1001/jama.1995.03530230056031
  • Chevreau M, Romand X, Gaudin P, Juvin R, Baillet A. Bisphosphonates for treatment of complex regional pain syndrome type 1: a systematic literature review and meta-analysis of randomized controlled trials versus placebo. Joint Bone Spine. 2017;84(4):393–399. doi:10.1016/j.jbspin.2017.03.009
  • van den Berg C, de Bree PN, Huygen FJPM, Tiemensma J. Glucocorticoid treatment in patients with complex regional pain syndrome: a systematic review. Eur J Pain. 2022;26(10):2009–2035. doi:10.1002/ejp.2025
  • Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain. Neurology. 2008;70(18):1630. doi:10.1212/01.wnl.0000282763.29778.59
  • Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157(8):1599. doi:10.1097/j.pain.0000000000000492
  • Freynhagen R, Baron R, Gockel U, Tölle TR. Pain DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911–1920. doi:10.1185/030079906X132488
  • Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1–2):29–36. doi:10.1016/j.pain.2004.12.010
  • Rolke R, Magerl W, Campbell KA, et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain. 2006;10(1):77–88. doi:10.1016/j.ejpain.2005.02.003
  • Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009;65(6):629–638. doi:10.1002/ana.21692
  • Nelson CN, Glauser G, Kessler RA, Jack MM. Causalgia: a military pain syndrome. Neurosurg Focus. 2022;53(3):E9. doi:10.3171/2022.6.FOCUS22270
  • Naleschinski D, Baron R. Complex regional pain syndrome type I: neuropathic or not? Curr Pain Headache Rep. 2010;14(3):196–202. doi:10.1007/s11916-010-0115-9
  • van der Laan L, ter Laak HJ, Gabreels-Festen A, Gabreels F, Goris RJ. Complex regional pain syndrome type I (RSD): pathology of skeletal muscle and peripheral nerve. Neurology. 1998;51(1):20–25. doi:10.1212/WNL.51.1.20
  • Oaklander AL, Rissmiller JG, Gelman LB, Zheng L, Chang Y, Gott R. Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy). Pain. 2006;120(3):235–243. doi:10.1016/j.pain.2005.09.036
  • Albrecht PJ, Hines S, Eisenberg E, et al. Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain. 2006;120(3):244–266. doi:10.1016/j.pain.2005.10.035
  • Kharkar S, Venkatesh YS, Grothusen JR, Rojas L, Schwartzman RJ. Skin biopsy in complex regional pain syndrome: case series and literature review. Pain Physician. 2012;15(3):255–266.
  • Finch PM, Drummond ES, Dawson LF, Phillips JK, Drummond PD. Up-regulation of cutaneous α1-adrenoceptors in complex regional pain syndrome type I. Pain Med. 2014;15(11):1945–1956. doi:10.1111/pme.12548
  • Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018;129(2):343–366. doi:10.1097/ALN.0000000000002130
  • Javed S, Abdi S. Use of anticonvulsants and antidepressants for treatment of complex regional pain syndrome: a literature review. Pain Manag. 2021;11(2):189–199. doi:10.2217/pmt-2020-0060
  • Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382–1386. doi:10.1097/j.pain.0000000000000507
  • Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–S15. doi:10.1016/j.pain.2010.09.030
  • Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44(3):293–299. doi:10.1016/0304-3959(91)90100-C
  • Kosek E, Clauw D, Nijs J, et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain. 2021;162(11):2629–2634. doi:10.1097/j.pain.0000000000002324
  • Cohen ML. Proposed clinical criteria for nociplastic pain in the musculoskeletal system are flawed. Pain. 2022;163(4):e604. doi:10.1097/j.pain.0000000000002505
  • Brummett CM, Bakshi RR, Goesling J, et al. Preliminary validation of the Michigan body map. Pain. 2016;157(6):1205–1212. doi:10.1097/j.pain.0000000000000506
  • Mayer TG, Neblett R, Cohen H, et al. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12(4):276–285. doi:10.1111/j.1533-2500.2011.00493.x
  • Arendt-Nielsen L, Morlion B, Perrot S, et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain. 2018;22(2):216–241. doi:10.1002/ejp.1140
  • Treede R-D, Hoheisel U, Wang D, Magerl W. Central sensitization: clinical utility of a physiological concept for the International Statistical Classification of Diseases and Related Health Problems and for nociplastic pain. Pain. 2022;163(S1). doi:10.1097/j.pain.0000000000002740
  • De Schoenmacker I, Mollo A, Scheuren PS, et al. Central sensitization in CRPS patients with widespread pain: a cross-sectional study. Pain Med. 2023;24:974–984. doi:10.1093/pm/pnad040
  • Drummond PD, Finch PM, Birklein F, Stanton-Hicks M, Knudsen LF. Hemisensory disturbances in patients with complex regional pain syndrome. Pain. 2018;159(9):1824–1832. doi:10.1097/j.pain.0000000000001280
  • Reimer M, Rempe T, Diedrichs C, Baron R, Gierthmühlen J. Sensitization of the nociceptive system in complex regional pain syndrome. PLoS One. 2016;11(5):e0154553. doi:10.1371/journal.pone.0154553
  • Drummond PD, Finch PM. Sensory changes in the forehead of patients with complex regional pain syndrome. Pain. 2006;123(1–2):83–89. doi:10.1016/j.pain.2006.02.013
  • Knudsen L, Finch PM, Drummond PD. The specificity and mechanisms of hemilateral sensory disturbances in complex regional pain syndrome. J Pain. 2011;12(9):985–990. doi:10.1016/j.jpain.2011.03.001
  • van Rooijen DE, Marinus J, van Hilten JJ. Muscle hyperalgesia is widespread in patients with complex regional pain syndrome. Pain. 2013;154(12):2745–2749. doi:10.1016/j.pain.2013.08.004
  • Sieweke N, Birklein F, Riedl B, Neundorfer B, Handwerker HO. Patterns of hyperalgesia in complex regional pain syndrome. Pain. 1999;80(1–2):171–177. doi:10.1016/S0304-3959(98)00200-0
  • Seifert F, Kiefer G, DeCol R, Schmelz M, Maihöfner C. Differential endogenous pain modulation in complex-regional pain syndrome. Brain. 2009;132(3):788–800. doi:10.1093/brain/awn346
  • Llewellyn A, Buckle L, Grieve S, et al. Delphi study to define core clinical outcomes for inclusion in a complex regional pain syndrome international research registry and data bank. Pain. 2023;164(3):543–554. doi:10.1097/j.pain.0000000000002729
  • Di Pietro F, McAuley JH, Parkitny L, et al. Primary somatosensory cortex function in complex regional pain syndrome: a systematic review and meta-analysis. J Pain. 2013;14(10):1001–1018. doi:10.1016/j.jpain.2013.04.001
  • Di Pietro F, Stanton TR, Moseley GL, Lotze M, McAuley JH. Interhemispheric somatosensory differences in chronic pain reflect abnormality of the healthy side. Hum Brain Mapp. 2015;36(2):508–518. doi:10.1002/hbm.22643
  • Pleger B, Tegenthoff M, Ragert P, et al. Sensorimotor returning in complex regional pain syndrome parallels pain reduction. Ann Neurol. 2005;57(3):425–429. doi:10.1002/ana.20394
  • Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Cortical reorganization during recovery from complex regional pain syndrome. Neurology. 2004;63(4):693–701. doi:10.1212/01.WNL.0000134661.46658.B0
  • Maihöfner C, Forster C, Birklein F, Neundörfer B, Handwerker HO. Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study. Pain. 2005;114(1):93–103. doi:10.1016/j.pain.2004.12.001
  • Di Pietro F, Lee B, Henderson LA. Altered resting activity patterns and connectivity in individuals with complex regional pain syndrome. Hum Brain Mapp. 2020;41(13):3781–3793. doi:10.1002/hbm.25087
  • Schwenkreis P, Maier C, Tegenthoff M. Functional imaging of central nervous system involvement in complex regional pain syndrome. Am J Neuroradiol. 2009;30(7):1279–1284. doi:10.3174/ajnr.A1630
  • Klega A, Eberle T, Buchholz HG, et al. Central opioidergic neurotransmission in complex regional pain syndrome. Neurology. 2010;75(2):129–136. doi:10.1212/WNL.0b013e3181e7ca2e
  • Freund W, Wunderlich AP, Stuber G, et al. The role of periaqueductal gray and cingulate cortex during suppression of pain in complex regional pain syndrome. Clin J Pain. 2011;27(9):796–804. doi:10.1097/AJP.0b013e31821d9063
  • Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Patterns of cortical reorganization in complex regional pain syndrome. Neurology. 2003;61(12):1707–1715. doi:10.1212/01.WNL.0000098939.02752.8E
  • Lee B, Henderson LA, Rae CD, Di Pietro F. CRPS is not associated with altered sensorimotor cortex GABA or glutamate. Eneuro. 2020;7(1). doi:10.1523/ENEURO.0389-19.2020
  • Jeon SY, Seo S, Lee JS, et al. [11C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome: a pilot study. Medicine (Baltimore). 2017;96(1):e5735. doi:10.1097/MD.0000000000005735
  • Jung Y-H, Kim H, Jeon SY, et al. Brain metabolites and peripheral biomarkers associated with neuroinflammation in complex regional pain syndrome using [11C]-(R)-PK11195 positron emission tomography and magnetic resonance spectroscopy: a pilot study. Pain Med. 2019;20(3):504–514. doi:10.1093/pm/pny111
  • van de Vusse AC, Stomp-van den Berg SG, Kessels AH, Weber WE. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1 [ISRCTN84121379]. BMC Neurol. 2004;4(1):13. doi:10.1186/1471-2377-4-13
  • Zhao J, Wang Y, Wang D. The effect of ketamine infusion in the treatment of complex regional pain syndrome: a systemic review and meta-analysis. Curr Pain Headache Rep. 2018;22(2):12. doi:10.1007/s11916-018-0664-x
  • Freynhagen R, Parada HA, Calderon-Ospina CA, et al. Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin. 2019;35(6):1011–1018. doi:10.1080/03007995.2018.1552042
  • Freynhagen R, Rey R, Argoff C. When to consider “mixed pain”? The right questions can make a difference! Curr Med Res Opin. 2020;36(12):2037–2046. doi:10.1080/03007995.2020.1832058
  • Kortekaas MC, Niehof SP, Stolker RJ, Huygen FJ. Pathophysiological mechanisms involved in vasomotor disturbances in complex regional pain syndrome and implications for therapy: a review. Pain Pract. 2016;16(7):905–914. doi:10.1111/papr.12403
  • Wasner G, Heckmann K, Maier C, Baron R. Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol. 1999;56(5):613–620. doi:10.1001/archneur.56.5.613
  • Drummond ES, Dawson LF, Finch PM, Bennett GJ, Drummond PD. Increased expression of cutaneous α1-adrenoceptors after chronic constriction injury in rats. J Pain. 2014;15(2):188–196. doi:10.1016/j.jpain.2013.10.010
  • Arnold JM, Teasell RW, MacLeod AP, Brown JE, Carruthers SG. Increased venous alpha-adrenoceptor responsiveness in patients with reflex sympathetic dystrophy. Ann Intern Med. 1993;118(8):619–621. doi:10.7326/0003-4819-118-8-199304150-00008
  • Groeneweg JG, Huygen FJ, Heijmans-Antonissen C, Niehof S, Zijlstra FJ. Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord. 2006;7(1):91. doi:10.1186/1471-2474-7-91
  • Koban M, Leis S, Schultze-Mosgau S, Birklein F. Tissue hypoxia in complex regional pain syndrome. Pain. 2003;104(1–2):149–157. doi:10.1016/S0304-3959(02)00484-0
  • Coderre TJ, Bennett GJ. A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology. Pain Med. 2010;11(8):1224–1238. doi:10.1111/j.1526-4637.2010.00911.x
  • Laferrière A, Millecamps M, Xanthos DN, et al. Cutaneous tactile allodynia associated with microvascular dysfunction in muscle. Mol Pain. 2008;4:1744–8069-4–49. doi:10.1186/1744-8069-4-49
  • Matsuda M, Huh Y, Ji -R-R. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J Anesth. 2019;33(1):131–139. doi:10.1007/s00540-018-2579-4
  • Cepeda MS, Lau J, Carr DB. Defining the therapeutic role of local anesthetic sympathetic blockade in complex regional pain syndrome: a narrative and systematic review. Clin J Pain. 2002;18(4). doi:10.1097/00002508-200207000-00002
  • Seidel MF, Hügle T, Morlion B, et al. Neurogenic inflammation as a novel treatment target for chronic pain syndromes. Exp Neurol. 2022;356:114108. doi:10.1016/j.expneurol.2022.114108
  • Dik WA, Heron M. Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases. Neth J Med. 2020;78(5):220–231.
  • Mangnus TJP, Bharwani KD, Dik WA, Baart SJ, Dirckx M, Huygen FJPM. Is there an association between serum soluble interleukin-2 receptor levels and syndrome severity in persistent complex regional pain syndrome? Pain Med. 2023;24:1234–1243. doi:10.1093/pm/pnad081
  • Smart KM, Ferraro MC, Wand BM, O’Connell NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II. Cochrane Database Syst Rev. 2022;5(5):CD010853. doi:10.1002/14651858.CD010853.pub3
  • de C Williams AC, Fisher E, Hearn L, Eccleston C. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020;8:1.
  • Kemler MA, Barendse GAM, van Kleef M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. 2000;343(9):618–624. doi:10.1056/NEJM200008313430904
  • Deer TR, Levy RM, Kramer J, et al. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain. 2017;158(4):669–681. doi:10.1097/j.pain.0000000000000814
  • Geurts JW, Smits H, Kemler MA, Brunner F, Kessels AG, van Kleef M. Spinal cord stimulation for complex regional pain syndrome type I: a prospective cohort study with long-term follow-up. Neuromodulation. 2013;16(6):523–9; discussion 529. doi:10.1111/ner.12024
  • Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain. 2012;153(6):1193–1198. doi:10.1016/j.pain.2012.02.021
  • Olesen SS, Graversen C, Bouwense SAW, van Goor H, Wilder-Smith OHG, Drewes AM. Quantitative sensory testing predicts pregabalin efficacy in painful chronic pancreatitis. PLoS One. 2013;8(3):e57963. doi:10.1371/journal.pone.0057963
  • Bosma RL, Cheng JC, Rogachov A, et al. Brain dynamics and temporal summation of pain predicts neuropathic pain relief from ketamine infusion. Anesthesiology. 2018;129(5):1015–1024. doi:10.1097/ALN.0000000000002417
  • Mangnus TJP, Dirckx M, Bharwani KD, et al. Intermittent versus continuous esketamine infusions for long-term pain modulation in complex regional pain syndrome: protocol of a randomized controlled non-inferiority study (KetCRPS-2). BMC Musculoskelet Disord. 2023;24(1):239. doi:10.1186/s12891-023-06258-4
  • Grieve S, Perez R, Birklein F, et al. Recommendations for a first core outcome measurement set for complex regional PAin syndrome Clinical sTudies (COMPACT). Pain. 2017;158(6):1083–1090. doi:10.1097/j.pain.0000000000000866
  • Kriek N, Schreurs MWJ, Groeneweg JG, et al. Spinal cord stimulation in patients with complex regional pain syndrome: a possible target for immunomodulation? Neuromodulation. 2018;21(1):77–86. doi:10.1111/ner.12704
  • Linderoth B, Foreman RD. Physiology of spinal cord stimulation: review and update. Neuromodulation. 1999;2(3):150–164. doi:10.1046/j.1525-1403.1999.00150.x
  • Knotkova H, Hamani C, Sivanesan E, et al. Neuromodulation for chronic pain. Lancet. 2021;397(10289):2111–2124. doi:10.1016/S0140-6736(21)00794-7
  • Sivanesan E, Maher DP, Raja SN, Linderoth B, Guan Y. Supraspinal mechanisms of spinal cord stimulation for modulation of pain: five decades of research and prospects for the future. Anesthesiology. 2019;130(4):651–665. doi:10.1097/ALN.0000000000002353
  • Thomson S, Huygen F, Prangnell S, et al. Appropriate referral and selection of patients with chronic pain for spinal cord stimulation: European consensus recommendations and e-health tool. Eur J Pain. 2020;24(6):1169–1181. doi:10.1002/ejp.1562